Cargando…

Invasive Pneumococcal Disease after Routine Pneumococcal Conjugate Vaccination in Children, England and Wales

We assessed known risk factors, clinical presentation, and outcome of invasive pneumococcal disease (IPD) in children 3–59 months of age after introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in England and Wales. During September 2006–March 2010, a total of 1,342 IPD episodes occu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ladhani, Shamez N., Slack, Mary P.E., Andrews, Nick J., Waight, Pauline A., Borrow, Ray, Miller, Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557991/ https://www.ncbi.nlm.nih.gov/pubmed/23259937 http://dx.doi.org/10.3201/eid1901.120741

Ejemplares similares

Using the Indirect Cohort Design to Estimate the Effectiveness of the Seven Valent Pneumococcal Conjugate Vaccine in England and Wales
por: Andrews, Nick, et al.
Publicado: (2011)

Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000–June 30, 2016
por: Oligbu, Godwin, et al.
Publicado: (2019)

Pneumococcal Serotype–specific Unresponsiveness in Vaccinated Child with Cochlear Implant
por: Stanford, Elaine, et al.
Publicado: (2012)

7-Valent Pneumococcal Conjugate Vaccination in England and Wales: Is It Still Beneficial Despite High Levels of Serotype Replacement?
por: Choi, Yoon Hong, et al.
Publicado: (2011)

Effectiveness of 23-Valent Polysaccharide Pneumococcal Vaccine and Changes in Invasive Pneumococcal Disease Incidence from 2000 to 2017 in Those Aged 65 and Over in England and Wales
por: Djennad, Abdelmajid, et al.
Publicado: (2019)

Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England
por: Southern, Jo, et al.
Publicado: (2018)

Effect of Pneumococcal Conjugate Vaccination on Serotype-Specific Carriage and Invasive Disease in England: A Cross-Sectional Study
por: Flasche, Stefan, et al.
Publicado: (2011)

Invasive Haemophilus influenzae Serotype e and f Disease, England and Wales
por: Ladhani, Shamez N., et al.
Publicado: (2012)

Rapid Spread of Pneumococcal Nonvaccine Serotype 7C Previously Associated with Vaccine Serotype 19F, England and Wales
por: Makwana, Ashley, et al.
Publicado: (2018)

Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study
por: Choi, Yoon Hong, et al.
Publicado: (2019)

Effect of Serotype on Focus and Mortality of Invasive Pneumococcal Disease: Coverage of Different Vaccines and Insight into Non-Vaccine Serotypes
por: van Hoek, Albert Jan, et al.
Publicado: (2012)

Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England
por: Bertran, Marta, et al.
Publicado: (2022)

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
por: Melegaro, Alessia, et al.
Publicado: (2010)

Invasive meningococcal disease in England: assessing disease burden through linkage of multiple national data sources
por: Ladhani, Shamez N, et al.
Publicado: (2015)

Invasive Meningococcal Capsular Group Y Disease, England and Wales, 2007–2009
por: Ladhani, Shamez N., et al.
Publicado: (2012)

Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015–2016
por: Campbell, Helen, et al.
Publicado: (2017)

Impact of Pneumococcal Conjugate Universal Routine Vaccination on Pneumococcal Disease in Italian Children
por: Fortunato, Francesca, et al.
Publicado: (2015)

Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use
por: Baxter, Roger, et al.
Publicado: (2020)

Mathematical Modelling Long-Term Effects of Replacing Prevnar7 with Prevnar13 on Invasive Pneumococcal Diseases in England and Wales
por: Choi, Yoon Hong, et al.
Publicado: (2012)

Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations
por: Naucler, Pontus, et al.
Publicado: (2017)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: van Deursen, Anna M.M., et al.
Publicado: (2012)

Estimating age-stratified influenza-associated invasive pneumococcal disease in England: A time-series model based on population surveillance data
por: Chiavenna, Chiara, et al.
Publicado: (2019)

Impact of COVID-19 social distancing measures on future incidence of invasive pneumococcal disease in England and Wales: a mathematical modelling study
por: Choi, Yoon Hong, et al.
Publicado: (2021)

Influenza and RSV make a modest contribution to invasive pneumococcal disease incidence in the UK
por: Nicoli, Emily J., et al.
Publicado: (2013)

Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16
por: Findlow, Helen, et al.
Publicado: (2019)

Historical Population-Level Impact of Infant 13-Valent Pneumococcal Conjugate Vaccine (PCV13) National Immunization Programs on Invasive Pneumococcal Disease in Australia, Canada, England and Wales, Israel, and the United States
por: Perdrizet, Johnna, et al.
Publicado: (2023)

Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control
por: Thorrington, Dominic, et al.
Publicado: (2018)

Invasive Meningococcal Disease, 2011–2020, and Impact of the COVID-19 Pandemic, England
por: Subbarao, Sathyavani, et al.
Publicado: (2021)

Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England()
por: Field, Nigel, et al.
Publicado: (2014)

Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
por: Nikolova, Kristiana Alexandrova, et al.
Publicado: (2021)

647 Impact of 13-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in the United States
por: Kim, Lindsay, et al.
Publicado: (2014)

Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants
por: Rückinger, Simon, et al.
Publicado: (2010)

1430. Evolving Impact of 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease
por: Yildirim, Inci, et al.
Publicado: (2018)

State of the Globe: Effect of Pneumococcal Conjugate Vaccines on Nonvaccine-type Invasive Pneumococcal Disease
por: Raina, Sunil Kumar
Publicado: (2019)

Does the rise in seasonal respiratory viruses foreshadow the return of invasive pneumococcal disease this winter?
por: Amin-Chowdhury, Zahin, et al.
Publicado: (2022)

Awareness Among Parents About Pneumococcal Conjugate Vaccine in Routine Immunization Program to Prevent Pneumococcal Pneumonia in Bangladesh
por: Luies, Sharmin K, et al.
Publicado: (2019)

Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England
por: van Hoek, Albert Jan, et al.
Publicado: (2016)

Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis
por: Rozenbaum, Mark H, et al.
Publicado: (2012)

Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015
por: Wagenvoort, Gertjan H J, et al.
Publicado: (2017)

180. Impact of Pneumococcal Conjugative Vaccine on Antibiotic Resistant Invasive Pneumococcal Disease in the United States
por: Bajema, Kristina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mm080ifope1b7jr3557j5bs638